Keyphrases
Acute Myocardial Infarction
100%
Secondary Prevention
100%
Odds Ratio
100%
Myocardial Infarction Patients
37%
Receptor Antagonist
25%
Non-persistence
25%
Adenosine Diphosphate Receptors
25%
Longitudinal Assessment
12%
Dialysis
12%
Clinical Features
12%
Atrial Fibrillation
12%
High Risk
12%
Aspirin
12%
Statins
12%
Beta-blockers
12%
Private Health Insurance
12%
Acute Coronary Syndrome
12%
Old Age
12%
Prescription Drugs
12%
Angiotensin Receptor Blockers
12%
Treatment Patterns
12%
Post-myocardial Infarction
12%
Outpatient Follow-up
12%
Sociodemographic Characteristics
12%
Logistic Regression Modeling
12%
Black Race
12%
Multivariable Logistic Regression
12%
Prescription Drug Costs
12%
Multivariable Modeling
12%
Medication Classes
12%
Treatment Assessment
12%
Long-standing Persistent
12%
Medication Persistence
12%
Financial Concerns
12%
Persistent Use
12%
High Persistence
12%
Angiotensin-converting Enzyme Inhibitor (ACEi)
12%
Medication Discontinuation
12%
Nursing and Health Professions
Odds Ratio
100%
Secondary Prevention
100%
Drug Therapy
100%
Acute Heart Infarction
100%
Heart Infarction
50%
Receptor
25%
Adenosine Diphosphate
25%
Acute Coronary Syndrome
12%
Dipeptidyl Carboxypeptidase Inhibitor
12%
Outpatient
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Logistic Regression Analysis
12%
Angiotensin Receptor Antagonist
12%
Side Effect
12%
Atrial Fibrillation
12%
Medicine and Dentistry
Secondary Prevention
100%
Drug Therapy
100%
Acute Heart Infarction
100%
Odds Ratio
100%
Myocardial Infarction
50%
Adenosine Diphosphate Receptor Inhibitor
25%
Health Care Cost
12%
Acetylsalicylic Acid
12%
Statin
12%
Outpatient
12%
Atrial Fibrillation
12%
Angiotensin Receptor Antagonist
12%
ACE Inhibitor
12%
Logistic Regression Analysis
12%
Side Effect
12%
Acute Coronary Syndrome
12%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
100%
Acute Heart Infarction
100%
Receptor
50%
Adenosine Diphosphate
50%
Acetylsalicylic Acid
25%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
25%
Side Effect
25%
Angiotensin Receptor Antagonist
25%
Acute Coronary Syndrome
25%
Dipeptidyl Carboxypeptidase Inhibitor
25%
Atrial Fibrillation
25%